Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles
US8840868B2 · kind B2 · utility
3Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2010 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Mar 2, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of non-invasive imaging of complement-mediated inflammation are provided. Compositions including CR-targeted ultrasmall superparamagnetic nanoparticles or aggregates thereof for use with those methods are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.